₹275.50
−1.69%NSE close, 16 Nov 2026
+42.82%
INFLUX HEALTHTECH is a small cap company, listed on NSE SME under the symbol INFLUX. At ₹275.50 a share, the market values the whole company at ₹638 crore. NSE SME is the exchange's platform for small and medium companies, which report their results every half year.
In FY26, it reported sales of ₹147 crore and a net profit of ₹21 crore, an operating margin of 20.3%.
The market values the company at 19.6 times its profit over the last twelve months and 5.66 times its book value; its return on equity is 28.9% and it has almost no borrowings.
Promoters hold 73.53% of the shares. Foreign institutions hold 0.41%, and domestic institutions, mutual funds among them, 7.33%.
Over the past year the share price has risen 39.1%, and it is 12.5% below its 52-week high.
Listed on NSE SME, the platform for small and medium companies: its shares trade in large lots and often thinly, so the price can move sharply on a few trades, and companies file results every half year.
₹ crore. Consolidated figures where the company filed them, standalone otherwise (marked S).
| Line | 6M to Sep 2025 S | 6M to Mar 2026 | 6M to Sep 2026 |
|---|---|---|---|
| Sales | 66.8 | 147 | 85.4 |
| Expenses | 52.1 | 117 | 67.1 |
| Operating profit | 14.7 | 29.9 | 18.3 |
| Operating margin | 22.0% | 20.3% | 21.5% |
| Other income | 0.1 |
Transcript of Investor Conference call held on November 5, 2026
Link of Recording of Investor Conference Call held on November 5, 2026
The financial results for the period ended September 30, 2026.
| 0.3 |
| Interest | 0 | 0.2 | 0.1 |
|---|
| Depreciation | 1.7 | 3.8 | 2.3 |
|---|
| Profit before tax | 13.1 | 27.2 | 16.2 |
|---|
| Tax | 3.1 | 6.7 | 4.2 |
|---|
| Net profit | 10.0 | 20.5 | 12.0 |
|---|
| EPS (₹) | 4.81 | 9.35 | 5.19 |
|---|
₹ crore, financial years to March.
| Line | FY26 |
|---|---|
| Sales | 147 |
| Expenses | 117 |
| Operating profit | 29.9 |
| Operating margin | 20.3% |
| Other income | 1.3 |
| Interest | 0.2 |
| Depreciation | 3.8 |
| Profit before tax | 27.2 |
| Tax | 6.7 |
| Net profit | 20.5 |
| EPS (₹) | 9.35 |
₹ crore, at each year's end and the latest half year.
₹ crore, by financial year, and the latest half year.
| Line | FY26 | 6M to Sep 2026 |
|---|---|---|
| From operations | 3.9 | 7.2 |
| From investing | −25.2 | −22.7 |
| From financing | 44.5 | 0 |
| Spent on fixed assets | −24.6 | −19.9 |
| Free cash flow | −20.7 | −12.7 |
Margins, returns, debt, tax and cash.
| Line | FY26 |
|---|---|
| Net margin | 14.0% |
| Operating margin | 20.3% |
| Return on equity | 20.4% |
| Return on capital employed | 27.2% |
| Return on assets | 16.6% |
| Debt to equity | 0.00 |
| Interest coverage | 152.30 |
| Debt to assets | 0.00 |
| Current ratio | 3.59 |
| Quick ratio | 2.89 |
| Cash ratio | 1.11 |
| Asset turnover | 1.19 |
| Fixed asset turnover | 5.33 |
| Inventory turnover | 5.40 |
| Receivables turnover | 4.30 |
| Gross margin | 41.0% |
| Cash from operations to profit | 19.0% |
| Effective tax rate | 24.6% |
The financial results for the period ended September 30, 2026.
The financial results for the period ended September 30, 2026.
Schedule of Investor Conference Call
Imposition of Fine by NSE Ltd.
Schedule of Analyst / Institutional Investor meetings
A copy of the Scrutiniser s Report and Voting Results of its 6th Annual General Meeting held on September 18, 2026.
Proceedings of Annual General Meeting held on September 18, 2026
Dispatch of Letters to Shareholders under Regulation 36(1)(b) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Notice of Annual General Meeting to be held on September 18, 2026
Outcome of Board Meeting held on August 26, 2026.
Business Update for the Quarter Ended June 30, 2026 (Q1FY27)